$EQBK

Elliott Brad S sold $234K of EQBK

Elliott Brad S (Chief Executive Officer) sold 4,581 shares of EQUITY BANCSHARES INC (EQBK) at an average of $51.11 ($51.02–$51.12, $0.23M total) across 2 trades over 2026-07-29 to 2026-07-30.

Original reporting
SEC EDGAR · Elliott Brad S
Published Jul 31, 2026, 1:29 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 31, 2026, 1:34 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$EQBK
Neutral
medium confidence
Mentioned
$EQBK
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$EQBKNeutralLow
01

Why it matters

The newest fact is the CEO’s open-market sale details and post-transaction holdings; it does not include any company performance or forward-looking statements.

02

Market read

Traders may monitor insider activity for sentiment, but this filing alone is unlikely to change valuation without accompanying fundamental catalysts.

03

What to watch

Insider sales can be driven by diversification, taxes, or pre-existing personal liquidity needs, and the filing does not indicate any change in company outlook.

Relevance 4/10Novelty 3/10Timing: filed 2026-07-31, covering sales on 2026-07-29 to 2026-07-30

Background

The article is an SEC Form 4 insider transaction disclosure for Equity Bancshares Inc.

Company-level read

Ticker impact

$EQBKNeutralMedium confidence
Context

Elliott Brad S, EQBK CEO and director, sold 4,581 shares in open-market transactions at about $51.02 to $51.12 per share.

Expected impact

Likely limited near-term impact; any reaction would be sentiment-driven rather than fundamental.

Evidence & confidence

Form 4 insider sales are common and the filing provides transaction details only, with no accompanying company-specific news, earnings, or operational update.

Market effects

No clear sector read-through from a single insider sale at a regional bank holding company.

None indicated.

None indicated.

Counterpoint

Absence of a pre-arranged 10b5-1 plan could be interpreted by some traders as less routine, potentially increasing short-term scrutiny.

Key entities

  • Elliott Brad S

    CEO and director of Equity Bancshares Inc, reported open-market sale of shares via Form 4.

  • Equity Bancshares Inc

    EQBK, the company whose insider sale was disclosed on SEC EDGAR.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$EQBKMed

Equity Bancshares (EQBK) Q3 2026 Earnings Call Transcript

Equity Bancshares (EQBK) reported Q3 2026 earnings, highlighting organic growth with loans up $39M to $5.44B and deposits down $136M to $6.17B. The company announced a merger with Lincoln Bancorp, adding 16 branches in Iowa. Net income was $26.8M, or $1.29 per diluted share. The company expects margin to return to 4.25-4.35% in Q4, excluding the merger.

$EQBKMed

StoneX lowers Equity Bancshares stock price target on NIM outlook

StoneX reduced its price target for Equity Bancshares (EQBK) to $58 from $59, citing net interest margin expectations. The firm raised its fiscal 2026 EPS forecast to $5.18 but lowered the 2027 estimate to $5.27. EQBK's stock trades at a P/E ratio of 10.58, and analysts expect net income growth. The company recently reported Q3 earnings beating estimates, with EPS of $1.40 vs. $1.29 expected, but revenue missed slightly.

$EQBKMed

Equity Bancshares Q3 2026 slides: EPS beats amid margin pressure

Equity Bancshares (EQBK) reported Q3 2026 earnings of $1.40 per share, beating estimates, though revenue fell slightly short. The stock rose 0.99% to $47.03. The bank faces margin pressure but continues growth through acquisitions, including the pending Lincoln Savings Bank deal. Asset quality showed some deterioration, with nonperforming assets rising to 0.99%. The company is investing in AI to improve efficiency.

$EQBKMed

Equity Bancshares (EQBK) Posts Solid Net Interest Income Despite

Equity Bancshares (EQBK) reported Q2 2026 net interest income of $72.8M, down slightly from the prior quarter but up 16.6% year-over-year. The company's GF Value™ suggests it is modestly undervalued with a 15.2% margin of safety. EQBK has a GF Score™ of 81/100, indicating strong fundamentals in valuation and momentum, but weaker financial strength. Insiders and gurus have shown net selling activity. The stock trades at $46.57 with a trailing P/E of 27.97x and a forward P/E of 8.55x.